News

New line of clay-based beauty products to hit market this summer

BY Antoinette Alexander

NEW YORK — Pharmaclay Delivery Systems has announced that it will introduce Clayspray, a line of clay-based beauty products targeting the face and body, to the U.S. market this summer.  

The collection will launch at three international beauty events: Premiere Orlando on June 1 to 3 in Orlando; The International Esthetics, Cosmetics & Spa Conference on June 22 to 24 in Las Vegas; and Cosmoprof North America on July 14 to 16 in Las Vegas.


The collection includes eight spray bottle clay emulsions that are available in both professional and retail sizes. Due to its patented delivery system, Clayspray remains fresh and at its optimal maturation level, achieving maximum efficacy and a longer shelf life, the manufacturer stated. There is no messy mixing or cleanup. Clayspray has a creamy texture that coats the face and body. It dries fast and washes off easily with no muddy residue.  


“Participating in these international trade events is a great opportunity to introduce Clayspray to the American market.  Clayspray is ‘the world’s first clay spray emulsion.’  It’s a revolutionary product for use in the facial masque category and one that fills a void in the marketplace for such a unique line of skin and body treatments,” stated Norberto Mugarza, GM Pharmaclay Laboratories.



Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Energizer Personal Care, The Skin Cancer Foundation aim to encourage sun safety among men

BY Antoinette Alexander

SHELTON, Conn. — Energizer Personal Care, which makes Banana Boat and Hawaiian Tropic brand sunscreens, has teamed up with the Skin Cancer Foundation to launch a public awareness campaign featuring Los Angeles Galaxy and Team USA soccer player Landon Donovan.

The awareness campaign is the second part of a two-year effort aimed at encouraging men to incorporate sun protection into their daily lives.

"Skin cancer is an important issue to me as my father was diagnosed with skin cancer, but thankfully it was caught early and he is doing great today," stated Donovan. "There is a misperception that sunscreen and other sun protection measures should only be used at the beach. Whether you’re spending time outdoors playing soccer, enjoying a round of golf or mowing the lawn, protecting yourself from the sun’s harmful UV rays is essential."

In the spring of 2012, the Skin Cancer Foundation and Energizer Personal Care together issued a survey to measure men’s knowledge of skin cancer and sun-protective behaviors. The survey confirmed a dramatic gender divide in sun protection and skin cancer awareness. Nearly half (49%) of men in the United States admitted to not using sunscreen in the past 12 months and 70% of men revealed that they did not know what skin cancer warning signs to look for. In almost every case, men were less knowledgeable than women about the proper methods to protect themselves against sun exposure and skin cancer. This is particularly concerning because over the last 30 years, the incidence of melanoma among men ages 18 to 39 has increased by 400% and men older than 50 are more than twice as likely as women to develop and die from skin cancer.

The campaign — which consists of print, digital, and television advertising, an interactive web site and a related sweepstakes — was developed to address the survey findings and to work toward closing the gender divide in skin cancer awareness.  Donovan is featured in the print ad as a visual example of what not to do when it comes to practicing proper sun care. He is also featured in a video and on the campaign website providing sun safety tips. The campaign encourages men to adopt a sun protection regimen that includes seeking shade, covering up with clothing, including a wide-brimmed hat and UV-blocking sunglasses, and wearing sunscreen every day.
 
The public can visit www.SunBlunders.com to learn the facts about skin cancer, sun exposure and the importance of sun protection. In addition, by visiting the website and taking the sun-smarts quiz, users are automatically entered into a sweepstakes for a chance to win a three-night guys’ getaway trip to Key West, Fla. for three. The trip includes the winner’s choice of a deep-sea fishing excursion or a day of golf.  

Energizer Personal Care is also a supporting sponsor of the Skin Cancer Foundation’s Road to Healthy Skin Tour, presented by Rite Aid. The tour, now in its sixth year, will travel across the country for four consecutive months. Local volunteer dermatologists provide free full-body skin cancer screenings to participants in a 38-foot RV customized with two exam rooms. To date, 16,000 people have received free skin cancer screenings through the tour and volunteer dermatologists have detected nearly 7,000 suspected precancers and cancers, including 295 suspected cases of melanoma. Educational materials that explain how to perform monthly skin checks at home and the proper ways to protect the skin from the sun on a daily basis are provided to tour participants, along with sunscreen samples and other giveaways.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Actavis, Warner Chilcott reach acquisition deal

BY Alaric DeArment

PARSIPPANY, N.J. — Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said Monday.

Actavis said its acquisition of the Dublin-based company would result in combined sales of about $11 billion, with a focus on women’s health, gastroenterology, urology and dermatology products. Actavis announced its intention to acquire Warner Chilcott two weeks ago, saying at the time that a deal had not been reached, though it announced last week that it had filed for approval of the deal with Irish regulators. As of Monday, the boards of directors of both companies have approved the deal, and it is expected to close by the end of this year.

"We have set as our strategic corporate objective to build a leading global specialty pharmaceutical company," Actavis president and CEO Paul Bisaro said. "The combination of Actavis and Warner Chilcott creates a strong specialty brand portfolio focused in therapeutic categories with strong growth potential and is supported by a deep pipeline of development programs."

While primarily a generic drug company, and the third-largest one at that, Actavis also has a significant presence in branded drugs, a presence that acquiring Warner Chilcott would bolster.

"The Warner Chilcott team has built a powerful specialty brands business with a strong pipeline, and this compelling transaction brings together two complementary organizations with the potential to create even more value for shareholders," Warner Chilcott president and CEO Roger Boissonneault said.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?